# Galectin Therapeutics Inc: Form 8-K, filed Sep 8, 2025

- Company: [Galectin Therapeutics Inc](/companies/galt.md) (CIK 1133416)
- Form: 8-K
- Filed: 2025-09-08
- Accepted by EDGAR: Sep 8, 2025, 11:56 ET
- Period: 2025-09-08
- Accession: 0001140361-25-034242
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1133416/000114036125034242/ef20055150_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1133416/000114036125034242/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1133416/000114036125034242/ef20055150_8k.htm

Filed Sep 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-034242. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.